loader2
NRI

Dec 10, 2024


Category

Equity

AUM (Cr.)

8,688.65

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.81

Sharpe Ratio

23.09

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (Bonus) -0.34 13.77 36.85 19.78 28 21.14
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS 2.7 9.22 31 19.07 22.97 18.55
Category Rank 9/4 7/4 6/4 7/4 7/4 4/4
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Samco Special Opportunities Fund - Regular (G) 9.9800 1.22 0.00 0.00 0.00 197.98 2.39 5,000.00 invest
SBI Magnum Global Fund (IDCW) 116.5654 0.93 13.73 9.27 16.85 6,549.98 1.88 5,000.00 invest
SBI Magnum Global Fund (G) 381.5666 0.93 13.73 9.27 16.85 6,549.98 1.88 5,000.00 invest
DSP Banking & Financial Services Fund - Reg (IDCW) 12.3880 0.91 23.88 0.00 0.00 992.59 0.00 100.00 invest
ICICI Pru Infrastructure Fund - (IDCW) 30.2100 -7.84 40.20 34.84 32.48 6,779.16 1.89 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 1,167.62 13.52 -3.68
Equity-Divi`s Lab. Nov 30, 2024 833.81 9.65 4.81
Equity-Lupin Nov 30, 2024 656.99 7.61 -6.23
Equity-Cipla Nov 30, 2024 475.51 5.50 -1.15
Equity-Apollo Hospitals Nov 30, 2024 443.06 5.13 -2.76
Equity-Dr Reddy`s Labs Nov 30, 2024 440.30 5.10 -1.28
Equity-Vijaya Diagnost. Nov 30, 2024 352.95 4.09 16.75
Equity-Ajanta Pharma Nov 30, 2024 289.96 3.36 -1.38
Equity-Medplus Health Nov 30, 2024 279.01 3.23 35.99
Reverse Repo-TREPS Nov 30, 2024 277.95 3.22 -27.93

latest news

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 13 December 2024 as the record date ...

Dec 11, 2024 09:26

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 14 November 2024 as the record date ...

Nov 12, 2024 09:59

Nippon India Mutual Fund announces change in Exit Load Structure

Nippon India Mutual Fund has announced change in exit load structure under ...

Oct 14, 2024 14:01

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 15 October 2024 as the record date f...

Oct 11, 2024 09:48

Nippon India Mutual Fund announces merger of Nippon India ETF Nifty CPSE Bond Plus SDL Sep 2024 50:50 merger into Nippon India Nifty AAA CPSE Bond Plu

Nippon India Mutual Fund has approved the merger of Nippon India ETF Nifty ...

Sep 16, 2024 11:10

Groww Mutual Fund announces change in Exit Load Structure

Groww Mutual Fund has announced change in exit load structure under followi...

Sep 14, 2024 12:47

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (Bonus)
Contact Persone : Sailesh Raj Bhan
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com